TMDX
TransMedics Group Inc
NASDAQ: TMDX · HEALTHCARE · MEDICAL DEVICES
$98.57
-2.66% today
Updated 2026-04-29
Market cap
$3.41B
P/E ratio
20.24
P/S ratio
5.62x
EPS (TTM)
$4.87
Dividend yield
—
52W range
$89 – $156
Volume
1.0M
WallStSmart proprietary scores
64
out of 100
Grade: C+
Hold
Investment rating
10.0
Growth
A+6.0
Quality
B8.0
Profitability
A7.0
Valuation
B+4/9
Piotroski F-Score
Moderate
1.3
Altman Z-Score
Distress
—
Industry rank
—
View all highly rated stocks (75+) →202 stocks currently score above 75
Price targets
Analyst target
$156.00
+58.26%
12-Month target
$121.88
+23.65%
Intrinsic (DCF)
$308.61
Margin of safety
+56.81%
2 Strong Buy7 Buy2 Hold0 Sell0 Strong Sell
Price chart
X-Ray snapshot
Strengths
+ Profit margin 31.40% — above average
+ ROE 54.20% — strong efficiency
+ Free cash flow $19.00M — positive
+ Revenue growth 32.20% QoQ
+ 56.81% below intrinsic value
Risks
- Altman Z 1.33 — distress zone
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $93.46M | $241.62M | $441.54M | $605.49M | $605.49M |
| Net income | $-36.23M | $-25.03M | $35.46M | $190.29M | $105.38M |
| EPS | — | — | — | — | $4.87 |
| Free cash flow | $-57.72M | $-192.09M | $-80.94M | $133.59M | $19.00M |
| Profit margin | -38.77% | -10.36% | 8.03% | 31.43% | 31.40% |
Peer comparison
Smart narrative
TransMedics Group Inc trades at $98.57. representing a P/E of 20.24x trailing earnings. Our Smart Value Score of 64/100 indicates the stock is good. The company scores 4/9 on the Piotroski F-Score. With an Altman Z-Score of 1.33, it sits in the distress. TTM revenue stands at $605.49M. with profit margins at 31.40%. Our DCF model estimates intrinsic value at $308.61.
Frequently asked questions
What is TransMedics Group Inc's stock price?
TransMedics Group Inc (TMDX) trades at $98.57.
Is TransMedics Group Inc overvalued?
Smart Value Score 64/100 (Grade C+, Hold). DCF value $308.61.
What is the price target of TransMedics Group Inc (TMDX)?
The analyst target price is $156.00, representing +58.3% upside from the current price of $98.57.
What is the intrinsic value of TransMedics Group Inc (TMDX)?
Based on our DCF model, intrinsic value is $308.61, a +56.8% margin of safety versus $98.57.
What is TransMedics Group Inc's revenue?
TTM revenue is $605.49M.
Piotroski F-Score?
4/9 — moderate financial health.
Altman Z-Score?
1.33 — distress.
Company info
SectorHEALTHCARE
IndustryMEDICAL DEVICES
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio5.62x
ROE54.20%
Beta2.08
50D MA$118.69
200D MA$122.73
Shares out0.03B
Float0.03B
Short ratio—
Avg volume1.0M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—